
-
2002
Company Description
Fenix Biotech develops an innovative nano-delivery system for the treatment of monogenic diseases.
Fenix Biotech is developing the nanocapsules based on a nano-encapsulation technological platform using chitosan. The project's aim is to carry out a quick and focused therapeutical test, which validates the technology of the DNA nano-encapsulation, to treat monogenetic diseases.
-
Manufacturer:
Science and Engineering -
Formed:
2002 -
Company Website:
-
Company E-mail:
-
Company Address:
Pza de la Encina, 10-11, NĂșcleo 1, 3ÂȘ Planta, Tres CantosMadridSpain -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits